A detailed history of Jain Global LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Jain Global LLC holds 31,678 shares of RZLT stock, worth $313,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,678
Holding current value
$313,928
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$4.42 - $9.34 $140,016 - $295,872
31,678 New
31,678 $294,000
Q1 2025

May 15, 2025

BUY
$2.73 - $5.57 $134,444 - $274,305
49,247 New
49,247 $142,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $385M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.